BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37902006)

  • 1. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
    Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
    Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 4. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
    Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia.
    Ruan GT; Deng L; Xie HL; Shi JY; Liu XY; Zheng X; Chen Y; Lin SQ; Zhang HY; Liu CA; Ge YZ; Song MM; Hu CL; Zhang XW; Yang M; Hu W; Cong MH; Zhu LC; Wang KH; Shi HP
    Cancer Metab; 2024 Jan; 12(1):3. PubMed ID: 38273418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition-inflammation marker enhances prognostic value to ECOG performance status in overweight or obese patients with cancer.
    Zhang X; Zhang Q; Tang M; Zhang KP; Zhang XW; Song MM; Ruan GT; Sun Q; Li W; Xu HX; Cong MH; Deng L; Shi HP
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):109-119. PubMed ID: 35589385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
    Dolan RD; Laird BJA; Klepstad P; Kaasa S; Horgan PG; Paulsen Ø; McMillan DC
    Medicine (Baltimore); 2019 Sep; 98(37):e17019. PubMed ID: 31517821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
    Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
    Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
    Eren T
    ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
    Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
    Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
    Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
    Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
    Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia.
    Ruan GT; Zhang Q; Zhang X; Tang M; Song MM; Zhang XW; Li XR; Zhang KP; Ge YZ; Yang M; Li QQ; Chen YB; Yu KY; Cong MH; Li W; Wang KH; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1969-1982. PubMed ID: 34585849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
    Read JA; Choy ST; Beale PJ; Clarke SJ
    Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
    Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
    Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
    Huang JX; Zhang X; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
    BMC Cancer; 2024 Mar; 24(1):293. PubMed ID: 38438901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
    Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
    Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.
    Hwang JE; Kim HN; Kim DE; Choi HJ; Jung SH; Shim HJ; Bae WK; Hwang EC; Cho SH; Chung IJ
    BMC Cancer; 2011 Nov; 11():489. PubMed ID: 22103888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
    Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
    Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.